Loading…
Toward continuous crystallization of Urea-Barbituric acid: a polymorphic co-crystal system
Pharmaceutical co-crystals are multicomponent molecular systems typically formed through hydrogen bonding of a co-former molecule with the active pharmaceutical ingredient (API). Just as many single component molecular structures can exhibit polymorphism due to the geometry of hydrogen bond donors a...
Saved in:
Main Authors: | , , , , , , |
---|---|
Format: | Default Article |
Published: |
2015
|
Subjects: | |
Online Access: | https://hdl.handle.net/2134/19099 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
_version_ | 1818172599961649152 |
---|---|
author | Keddon Powell Giulia Bartolini Kate E. Wittering Ali N. Saleemi Chick C. Wilson Chris Rielly Zoltan Nagy |
author_facet | Keddon Powell Giulia Bartolini Kate E. Wittering Ali N. Saleemi Chick C. Wilson Chris Rielly Zoltan Nagy |
author_sort | Keddon Powell (1228920) |
collection | Figshare |
description | Pharmaceutical co-crystals are multicomponent molecular systems typically formed through hydrogen bonding of a co-former molecule with the active pharmaceutical ingredient (API). Just as many single component molecular structures can exhibit polymorphism due to the geometry of hydrogen bond donors and acceptors, the same is true for pharmaceutical co-crystals. In this study, the selective cocrystallization of the desired polymorphic form of urea-barbituric acid (UBA) co-crystals (forms I and III) is demonstrated, applying a novel periodic mixed suspension mixed product removal (PMSMPR) crystallizer cascade. The process was monitored using an integrated process analytical technology (PAT) array consisting of Raman spectroscopy, attenuated total reflectance ultraviolet/visible (ATRUV/ vis) spectroscopy, focused beam reflectance measurement (FBRM), particle vision microscopy (PVM), and an in-house developed commercial crystallization process informatics system (CryPRINS) software tool to determine when a “state of controlled operation” (SCO) was achieved. Three different start-up strategies were employed and their ability to produce selectively a particular polymorphic form of UBA was evaluated. The experimental conditions for producing pure UBA form I were optimized, but pure UBA form III remained elusive. Off-line characterization of the UBA polymorphs was carried out using Powder X-ray Diffraction (PXRD) and Raman spectroscopy. |
format | Default Article |
id | rr-article-9241352 |
institution | Loughborough University |
publishDate | 2015 |
record_format | Figshare |
spelling | rr-article-92413522015-09-14T00:00:00Z Toward continuous crystallization of Urea-Barbituric acid: a polymorphic co-crystal system Keddon Powell (1228920) Giulia Bartolini (1515979) Kate E. Wittering (1354260) Ali N. Saleemi (1515976) Chick C. Wilson (1310187) Chris Rielly (1254369) Zoltan Nagy (1254105) Inorganic chemistry not elsewhere classified Chemical engineering not elsewhere classified untagged Chemical Engineering not elsewhere classified Inorganic Chemistry Pharmaceutical co-crystals are multicomponent molecular systems typically formed through hydrogen bonding of a co-former molecule with the active pharmaceutical ingredient (API). Just as many single component molecular structures can exhibit polymorphism due to the geometry of hydrogen bond donors and acceptors, the same is true for pharmaceutical co-crystals. In this study, the selective cocrystallization of the desired polymorphic form of urea-barbituric acid (UBA) co-crystals (forms I and III) is demonstrated, applying a novel periodic mixed suspension mixed product removal (PMSMPR) crystallizer cascade. The process was monitored using an integrated process analytical technology (PAT) array consisting of Raman spectroscopy, attenuated total reflectance ultraviolet/visible (ATRUV/ vis) spectroscopy, focused beam reflectance measurement (FBRM), particle vision microscopy (PVM), and an in-house developed commercial crystallization process informatics system (CryPRINS) software tool to determine when a “state of controlled operation” (SCO) was achieved. Three different start-up strategies were employed and their ability to produce selectively a particular polymorphic form of UBA was evaluated. The experimental conditions for producing pure UBA form I were optimized, but pure UBA form III remained elusive. Off-line characterization of the UBA polymorphs was carried out using Powder X-ray Diffraction (PXRD) and Raman spectroscopy. 2015-09-14T00:00:00Z Text Journal contribution 2134/19099 https://figshare.com/articles/journal_contribution/Toward_continuous_crystallization_of_Urea-Barbituric_acid_a_polymorphic_co-crystal_system/9241352 CC BY-NC-ND 4.0 |
spellingShingle | Inorganic chemistry not elsewhere classified Chemical engineering not elsewhere classified untagged Chemical Engineering not elsewhere classified Inorganic Chemistry Keddon Powell Giulia Bartolini Kate E. Wittering Ali N. Saleemi Chick C. Wilson Chris Rielly Zoltan Nagy Toward continuous crystallization of Urea-Barbituric acid: a polymorphic co-crystal system |
title | Toward continuous crystallization of Urea-Barbituric acid: a polymorphic co-crystal system |
title_full | Toward continuous crystallization of Urea-Barbituric acid: a polymorphic co-crystal system |
title_fullStr | Toward continuous crystallization of Urea-Barbituric acid: a polymorphic co-crystal system |
title_full_unstemmed | Toward continuous crystallization of Urea-Barbituric acid: a polymorphic co-crystal system |
title_short | Toward continuous crystallization of Urea-Barbituric acid: a polymorphic co-crystal system |
title_sort | toward continuous crystallization of urea-barbituric acid: a polymorphic co-crystal system |
topic | Inorganic chemistry not elsewhere classified Chemical engineering not elsewhere classified untagged Chemical Engineering not elsewhere classified Inorganic Chemistry |
url | https://hdl.handle.net/2134/19099 |